Matrix metalloproteinase 3 haplotypes and plasma amyloid beta levels: The Rotterdam Study

Neurobiology of Aging

Volumn 31, Issue 4, 2010, Pages 715-718

  Reitz, Christiane ^a,b   van Rooij, Frank J A ^a   Soares, Holly D ^c   de Maat, Moniek P M ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a   Breteler, Monique M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Amyloid beta levels; Haplotypes; Matrix metalloproteinase 3

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; DNA; STROMELYSIN;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; GENE CONSTRUCT; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; NETHERLANDS; NEURONS; PEPTIDE FRAGMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; SENILE PLAQUES;

EID: 77049084746     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.05.033     Document Type: Article

References (13)

1. Backstrom J.R., Lim G.P., Cullen M.J., Tokes Z.A. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J. Neurosci. 1996, 16(24):7910-7919.
2. Chen M., Inestrosa N.C., Ross G.S., Fernandez H.L. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem. Biophys. Res. Commun. 1995, 213(1):96-103.
3. Deane R., Du Y.S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 2003, 9(7):907-913.
4. Deb S., Wenjun Z.J., Gottschall P.E. Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes. Brain Res. 2003, 970(1-2):205-213.
5. DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., Holtzman D.M. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 2002, 295(5563):2264-2267.
6. Hofman A., Breteler M.M., van Duijn C.M., Krestin G.P., Pols H.A., Stricker B.H., Tiemeier H., Uitterlinden A.G., Vingerling J.R., Witteman J.C. The Rotterdam Study: objectives and design update. Eur. J. Epidemiol. 2007, 22(11):819-829.
7. Hofman A., Grobbee D.E., de Jong P.T., van den Ouweland F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur. J. Epidemiol. 1991, 7(4):403-422.
8. Mehta P.D., Pirttila T., Mehta S.P., Sersen E.A., Aisen P.S., Wisniewski H.M. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch. Neurol. 2000, 57(1):100-105.
9. Qiu W.Q., Ye Z., Kholodenko D., Seubert P., Selkoe D. Degradation of amyloid β-protein by a metalloproteinase secreted by microglia and other neural and non-neural cells. J. Biol. Chem. 1997, 272(10):6641-6646.
10. Roher A.E., Kasunic T.C., Woods A.S., Cotter R.J., Ball M.J., Fridman R. Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A. Biochem. Biophys. Res. Commun. 1994, 205(3):1755-1761.
11. White A.R., Du T., Laughton K.M., Volitakis I., Sharples R.A., Xilinas M.E., Hoke D.E., Holsinger R.M., Evin G., Cherny R.A., Hill A.F., Barnham K.J., Li Q.X., Bush A.I., Masters C.L. Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J. Biol. Chem. 2006, 281(26):17670-17680.
12. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., Silverstein S.C., Husemann J. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 2003, 9(4):453-457.
13. Yin K.J., Cirrito J.R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F.F., Turk J., Xu J., Hsu C.Y., Mills J.C., Holtzman D.M., Lee J.M. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 2006, 26(43):10939-10948.